LCTX

#3096
Lineage Cell Therapeutics, Inc.
1.5900 USD
+6.00%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
1.5750
1.5900
年范围
1.4200
1.9850
日变化
+6.00%
每月变动
+1.27%
6个月变化
-7.40%
年变化
-7.40%
前一天收盘价
1.5000
开盘价
1.5750
买价
卖价
最低价
1.5750
High
1.5900
交易量
240
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 396.0492 M
  • Employee 77
  • Founded 1990
  • CEO N/A
  • Website www.lineagecell.com
  • Headquarter California, United States
  • FIGI BBG000G8RJY6
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-5.96
市销率
26.4

Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.

新闻